The AAM S&P 500 High Dividend Value ETF (SPDV) selects high-yield, value-driven stocks from the S&P 500 while limiting sector concentration to ensure diversification. Its top holdings include financially strong companies like Johnson & Johnson, Microsoft, Visa, and Broadcom, which provide a durable and growing dividend stream backed by solid free cash flow. Although Lockheed Martin shows some cash flow weakness, the overall portfolio remains balanced and sustainable. SPDV's approach delivers steady income with a value tilt, making it a reliable option for dividend-focused investors heading into the latter half of 2026.
A recent study by Spherix Global Insights highlights the unmet need for new treatments in warm autoimmune hemolytic anemia (w-AIHA), especially beyond second-line therapies where no clear standard exists. Current treatments rely heavily on corticoste...
Johnson & Johnson announced that its drug IMAAVY (nipocalimab-aahu) achieved a significant and durable hemoglobin response in patients with warm autoimmune hemolytic anemia (wAIHA) during a Phase 2/3 trial. Patients receiving the 30 mg/kg dose showed...
Johnson & Johnson continues to attract investors with its leaner business model focused on innovative medicine and medical technology after spinning off Kenvue. The company raised its dividend by 3.1%, marking 64 years of consecutive growth, supporte...
With interest rates stabilizing in mid-2026, investors are focusing on Dividend Kings and Aristocrats known for decades of consecutive dividend increases. Johnson & Johnson, Coca-Cola, and McDonald's stand out for their strong Q1 earnings, reasonable...
The SNPD ETF focuses on companies with long histories of increasing dividends, such as Johnson & Johnson, Coca-Cola, Procter & Gamble, PepsiCo, and Lowe's. These companies have strong free cash flow coverage supporting their payouts, making SNPD's di...
